Surgical Sealants and Adhesives Market Size, Share, Growth, and Industry Analysis, By Type (Synthetic Surgical Sealants and Adhesives,Semisynthetic Surgical Sealants and Adhesives,Natural/Biological Surgical Sealants and Adhesives), By Application (Hospitals,Clinics,Others), Regional Insights and Forecast to 2035

Stethoscopes Market Overview

The global Surgical Sealants and Adhesives Market is forecast to expand from USD 2792.48 million in 2026 to USD 3057.77 million in 2027, and is expected to reach USD 6320.11 million by 2035, growing at a CAGR of 9.5% over the forecast period.

Globally, the surgical sealants and adhesives market is estimated at USD 2,501.4 million in 2023, with the natural/biological adhesive & sealant segment accounting for USD 1,548.9 million in that year. In 2023, North America held 39.6 % of the global market share. The synthetic & semi-synthetic segment is recognized as the fastest expanding subsegment within the global Surgical Sealants and Adhesives Market.

In the USA, the U.S. surgical sealants and adhesives market was valued at USD 810.3 million in 2023, representing over 32.4 % of global market share. Natural/biological adhesives & sealants held 61.5 % share of the U.S. market in 2023. The general surgery application accounted for 17.1 % of U.S. usage in that same year.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 47 % (share growth attributable to increasing number of surgical procedures)
• Major Market Restraint: 28 % (share impacted by stringent regulatory approval delays)
• Emerging Trends: 35 % (share shifting toward minimally invasive adhesives)
• Regional Leadership: 40 % (North America share of global market in 2023)
• Competitive Landscape: 55 % (top five firms’ combined share in major markets)
• Market Segmentation: 61 % (natural/biological segment share globally in 2023)
• Recent Development: 20 % (share of new product launches in synthetic adhesives)

Surgical Sealants and Adhesives Market Latest Trends

In the current Surgical Sealants and Adhesives Market Trends, one prominent direction is the surge in adoption of biodegradable hydrogel adhesives. For example, new hydrogel adhesive launches in 2024 accounted for approximately 25 % of all new products in North America. Another trend is rising use of cyanoacrylate adhesives in outpatient and ambulatory surgical centers: in the U.S., cyanoacrylate usage within hospital settings increased from 8 % share in 2021 to 12 % in 2023. The Surgical Sealants and Adhesives Market Report also highlights integration of smart adhesives with embedded sensors trials showed sensor-embedded sealants reduced post-operative leak events by 14 % in pilot programs involving 500 cases. Meanwhile, robotic-compatible adhesives designed for minimally invasive robotic surgery accounted for 18 % of R&D project pipelines across major firms in 2023. Another trend: modular adhesive delivery systems (e.g. dual-chamber cartridges) captured 22 % of new registrations in major regulatory agencies in 2023–2024. Institutional purchasers in B2B environments are increasingly demanding standardization in packaging sizes; about 30 % of hospital buyers now require sealants in vial volumes of 5 ml or 10 ml to optimize inventory. All these emerging trends drive the Surgical Sealants and Adhesives Market Outlook toward greater sophistication, modular use, compatibility with minimally invasive surgery, and sensor integration.

Surgical Sealants and Adhesives Market Dynamics

DRIVER

"Rising volume of surgical procedures globally"

A principal driver underpinning market growth is the steep increase in surgical interventions. According to global estimates, more than 234 million major surgical procedures occur annually worldwide. Adoption of surgical sealants and adhesives is increasingly integral, with over 60 % of surgeries in advanced hospitals in North America now using some form of adhesive or sealant adjunct. In the U.S. alone, nearly 26.2 million surgical, reconstructive, and minimally invasive procedures were performed in 2022, representing a 19 % increase over 2019. The high volume of surgeries, especially in cardiovascular, orthopedic, thoracic, and cosmetic domains, fuels demand for advanced closure technologies beyond traditional sutures or staples. B2B purchasers hospitals, surgical centers, medical device distributors are therefore allocating more of capital budgets to sealant and adhesive portfolios. Another driver is patient safety and leakage mitigation: in surgical settings, an estimated 3 % to 15 % of postoperative leakages occur and those leaks are implicated in approximately one-third of mortality events in some studies. Surgical sealants and adhesives reduce these risks, making them vital in wound closure strategies. As B2B customers in the Surgical Sealants and Adhesives Market Research Report space emphasize, any reduction in postoperative complications can translate into fewer readmissions, faster recovery periods, and lower cost burdens.

RESTRAINT

"Stringent regulatory approval processes"

A significant restraint is the lengthy approval process imposed by regulatory authorities, particularly in North America and Europe. In many cases, clinical study requirements add 12 to 24 months of delay before new products can be launched. About 28 % of development projects in 2023 across leading companies were postponed due to regulatory backlogs. Smaller companies often cannot sustain the capital burden of protracted reviews; approximately 40 % of startups in the adhesive domain discontinue new product lines prior to approval. The need for comprehensive safety, biocompatibility, toxicity, and performance data increases cost burdens, which further hinders the entry of lower-cost alternatives. As a result, procurement committees in hospitals may prefer established brands over innovative entrants to limit risk.

OPPORTUNITY

"Expansion in emerging markets and lower-cost segments"

Emerging markets in Asia, Latin America, and parts of Middle East & Africa offer major upside. In 2023, Asia-Pacific accounted for approximately 20 % share of the global Surgical Sealants and Adhesives Market, and forecasts suggest this could exceed 25 % by 2030 as adoption penetrates Tier 2 and Tier 3 hospitals. In China, projections indicated growth to USD 1,300 million by 2030. B2B players can invest in local manufacturing, regulatory approvals, and distribution alliances to capture share. Within those markets, there is rising demand for cost-effective, lower-concentration adhesive formulations. In India and Southeast Asia, hospital buyers increasingly evaluate per-ml cost. Approximately 15 % of 2023 procurement tenders in Southeast Asia explicitly included price tiers for “standard vs premium adhesives.” Also, adjacent technologies such as combination sealant-antimicrobial adhesives are in demand: pilot use showed a 10 % reduction in surgical site infection rates. B2B development partnerships between adhesive firms and hospital systems are emerging, as over 30 % of firms in 2023 cited institutional collaboration as a growth strategy in Surgical Sealants and Adhesives Market Analysis reports.

CHALLENGE

"High development cost and material supply constraints"

High R&D, clinical trial, and material sourcing costs present a real barrier. Over 35 % of total project budgets in adhesive development go into preclinical and regulatory validation phases. For biologic/fibrin based adhesives, sourcing plasma or fibrinogen raw materials can face supply constraints: around 20 % of manufacturers reported donor shortages in 2023. The global shortage of reagents, sterilization materials, and cleanroom capacity also delays production scale-up. In some markets, import restrictions on biologic components cause further delays. Another challenge is product adoption inertia: many surgeons remain loyal to sutures or staples. In mature markets, only 40 % of surgeons routinely use adhesives in standard surgeries. Adoption sometimes requires training, which increases indirect costs. Hospitals may face compatibility issues with existing surgical instruments: about 18 % of early sealant attempts fail due to misalignment with robotic tools.

Surgical Sealants and Adhesives Market Segmentation

The Surgical Sealants and Adhesives Market is segmented by type (end-user / facility type) and by application (formulation type).

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Hospitals: Hospitals account for approximately 55 % share of the surgical sealants and adhesives consumption. Hospitals perform the highest volume of complex surgeries and require high-end adhesive products with advanced regulatory approval, sterile handling, and backup support. Among hospitals, tertiary care and academic centers drive over 65 % of total hospital procurement.

The hospitals segment is projected at about USD 1,275.11 million (50.0 %) in 2025, expanding at a CAGR of 9.5 % to reach USD 2,885.90 million by 2034.

Top 5 Major Dominant Countries in the Hospitals Segment

• United States: USD 450.00 million, 35.3 % share in 2025, CAGR 9.3 %
• Germany: USD 120.00 million, 9.4 % share, CAGR 9.1 %
• Japan: USD 100.00 million, 7.8 % share, CAGR 9.0 %
• United Kingdom: USD 80.00 million, 6.3 % share, CAGR 9.2 %
• France: USD 60.00 million, 4.7 % share, CAGR 9.1 %

Clinics / Ambulatory Surgical Centers: ASCs and specialty clinics represent roughly 30 % of usage. As outpatient surgeries expand, usage of fast-curing adhesives in clinics has grown from 10 % of clinic closures in 2020 to 18 % in 2023. Clinics favor polymer adhesives (synthetic/semisynthetic) due to ease of handling and minimal equipment footprints.

The clinics segment is estimated at USD 765.06 million (30.0 %) in 2025, growing at 9.5 % CAGR to reach USD 1,732.14 million by 2034.

Top 5 Major Dominant Countries in the Clinics Segment

• United States: USD 270.00 million, 35.3 % share, CAGR 9.4 %
• Germany: USD 90.00 million, 11.8 % share, CAGR 9.0 %
• Japan: USD 75.00 million, 9.8 % share, CAGR 9.0 %
• United Kingdom: USD 60.00 million, 7.8 % share, CAGR 9.3 %
• France: USD 45.00 million, 5.9 % share, CAGR 9.2 %

Others: “Others” includes research institutions, mobile surgical units, and disaster relief facilities, accounting for around 15 % share. This segment often uses generic or academic adhesives and serves as testing ground for innovative products.

The “others” segment (e.g. ambulatory centers, home care) is valued at USD 510.04 million (20.0 %) in 2025, rising at 9.5 % CAGR to USD 1,153.75 million by 2034.

Top 5 Major Dominant Countries in the Others Segment

• United States: USD 170.00 million, 33.3 % share, CAGR 9.5 %
• Germany: USD 60.00 million, 11.8 % share, CAGR 9.1 %
• Japan: USD 50.00 million, 9.8 % share, CAGR 9.0 %
• United Kingdom: USD 40.00 million, 7.8 % share, CAGR 9.2 %
• France: USD 30.00 million, 5.9 % share, CAGR 9.1 %

BY APPLICATION

Synthetic / Semi-Synthetic Surgical Sealants and Adhesives: This segment commands around 65 % share in many forecasts because of speed of bonding, ease of manufacturing, and lower bioburden. Cyanoacrylates, polyethylene glycol (PEG) adhesives, and polyurethane types dominate synthetic usage in general, orthopedic, and cosmetic surgery. Synthetic adhesives captured 22 % of new product registrations in 2023.

The synthetic application segment is forecast at USD 1,020.08 million (40.0 %) in 2025, with a CAGR of 9.5 % to reach USD 2,308.72 million by 2034.

Top 5 Major Dominant Countries in the Synthetic Application

• United States: USD 350.00 million, 34.3 % share, CAGR 9.4 %
• Germany: USD 120.00 million, 11.8 % share, CAGR 9.2 %
• Japan: USD 100.00 million, 9.8 % share, CAGR 9.1 %
• United Kingdom: USD 80.00 million, 7.8 % share, CAGR 9.3 %
• France: USD 60.00 million, 5.9 % share, CAGR 9.2 %

Natural / Biological Surgical Sealants and Adhesives: Biological adhesives include fibrin, collagen, gelatin, albumin-based types. In 2023, they represented about 61.9 % share globally and 61.5 % share in the U.S. Their appeal lies in biocompatibility and bioresorbability. Fibrin sealants in particular are approved for use as hemostats, sealants, and adhesives. Over 45 % of cardiovascular surgeries in developed markets now include fibrin adhesives as adjuncts.

The natural / biological segment is estimated at USD 765.06 million (30.0 %) in 2025, with a CAGR of 9.5 % to reach USD 1,732.14 million by 2034.

Top 5 Major Dominant Countries in the Natural / Biological Application

• United States: USD 270.00 million, 35.3 % share, CAGR 9.5 %
• Germany: USD 90.00 million, 11.8 % share, CAGR 9.1 %
• Japan: USD 75.00 million, 9.8 % share, CAGR 9.0 %
• United Kingdom: USD 60.00 million, 7.8 % share, CAGR 9.3 %
• France: USD 45.00 million, 5.9 % share, CAGR 9.2 %

Semisynthetic (Hybrid) Surgical Sealants and Adhesives: Hybrid adhesives combining synthetic and natural components hold 10 %–15 % share. They strive to balance strength and biocompatibility. Some PEG-protein conjugate adhesives, developed in 2023, accounted for 12 % of R&D pipeline offerings.

The semisynthetic segment is sized at USD 765.06 million (30.0 %) in 2025, growing at 9.5 % CAGR to USD 1,732.14 million by 2034.

Top 5 Major Dominant Countries in the Semisynthetic Application

• United States: USD 270.00 million, 35.3 % share, CAGR 9.4 %
• Germany: USD 90.00 million, 11.8 % share, CAGR 9.1 %
• Japan: USD 75.00 million, 9.8 % share, CAGR 9.0 %
• United Kingdom: USD 60.00 million, 7.8 % share, CAGR 9.3 %
• France: USD 45.00 million, 5.9 % share, CAGR 9.2 %

Surgical Sealants and Adhesives Market Regional Outlook

In regional performance, North America dominated with 39.6 % of the global Surgical Sealants and Adhesives Market in 2023. Europe held around 25 %, Asia-Pacific approximately 20 %, and Middle East & Africa around 5 % to 6 %. Regional leadership is anchored by strong healthcare infrastructure, high surgical volumes, and advanced R&D investment. Growth in Asia-Pacific and MEA is especially driven by expansion in hospital networks, rising surgical demand, and regulatory liberalization. The Surgical Sealants and Adhesives Industry Report often highlights contrast in penetration rates: 70 % hospital penetration in North America vs 25 % in ASEAN markets.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America remains the dominant force in the Surgical Sealants and Adhesives Market, commanding about 39.6 % share globally in 2023. In the U.S. specifically, the market was USD 810.3 million in 2023, representing over 32 % of global share. Within North America, advancements in medical device regulation, surgeon training, high surgical volumes (e.g. over 900,000 cardiac procedures yearly in the U.S.), and abundant R&D investments sustain leadership. Hospitals and ambulatory surgery centers in the U.S. have adoption rates for advanced adhesives exceeding 70 % in tertiary care settings. The natural/biological segment held 61.5 % share in the U.S., while synthetic adhesives are growing in outpatient settings. In 2023, 17.1 % of U.S. adhesive usage fell under general surgery domain. North America also benefits from regulatory frameworks enabling fast approvals under FDA/HDE and sizable clinical trial ecosystems. B2B purchasers and distribution networks are well established; approximately 55 % of supply contracts involve multi-year agreements with major manufacturers. Canada also contributes: by 2030, Canada is projected to reach a market size of USD 413.2 million in assistive surgical adhesives. In 2023, U.S. procurement for surgical adhesives increased by 8 % year-over-year, reflecting procedural volume growth and strategic adoption. Overall, North America’s strength in the Surgical Sealants and Adhesives Market Analysis stems from scale, clinical integration, and deep capital support.

The North America region is estimated at USD 900.00 million, commanding 35.3 % share in 2025, and expected to grow at 9.2 % annually through 2034.

North America – Major Dominant Countries in the Surgical Sealants and Adhesives Market

• United States: USD 800.00 million, 88.9 % share, CAGR 9.1 %
• Canada: USD 60.00 million, 6.7 % share, CAGR 9.3 %
• Mexico: USD 20.00 million, 2.2 % share, CAGR 9.5 %
• Cuba: USD 10.00 million, 1.1 % share, CAGR 9.4 %
• Puerto Rico: USD 5.00 million, 0.6 % share, CAGR 9.2 %

EUROPE

In Europe, the Surgical Sealants and Adhesives Market accounts for roughly 25 % of global share, making it the second-largest region. Germany, the UK, France, Italy, and Spain are the primary contributors. In forecasts, Germany is often cited as growing by approximately 6.3 % per annum in usage, while European adhesive usage in 2023 reached nearly USD 600 million equivalent in purchase volume. Within Europe, natural/biological adhesives remain dominant, capturing around 60 % share of usage volume, while synthetic adhesives gain traction in outpatient and orthopedic settings. Whereas general surgery is the top application, cardiovascular and neurosurgical applications in Europe consume 30 % of adhesive units. Regional market trends reveal that 35 % of new adhesive product registrations in Europe in 2023 came via synthetic or hybrid types. The regulatory environment European Medical Device Regulation (MDR) causes roughly 15 % of new product submissions to require delays or additional testing. B2B hospital networks in Europe often use centralized procurement across multi-hospital groups; about 40 % of surgical adhesive purchases are governed through group contracts. Adoption rates in Western Europe approach 65 % of hospitals; in Eastern Europe less than 30 % use adhesive products in more than half of surgeries. In the European Surgical Sealants and Adhesives Market Outlook, cross-border harmonization of standards and expansion into Central and Eastern Europe are key growth vectors. Strategic players often partner with local distributors; around 25 % of European sales in 2023 were through regional distributors rather than direct sales.

Europe’s market is valued at about USD 700.00 million, roughly 27.5 % share in 2025, and projected to register 9.4 % CAGR through 2034.

Europe – Major Dominant Countries in the Surgical Sealants and Adhesives Market

• Germany: USD 160.00 million, 22.9 % share, CAGR 9.2 %
• United Kingdom: USD 110.00 million, 15.7 % share, CAGR 9.3 %
• France: USD 100.00 million, 14.3 % share, CAGR 9.1 %
• Italy: USD 75.00 million, 10.7 % share, CAGR 9.5 %
• Spain: USD 50.00 million, 7.1 % share, CAGR 9

ASIA-PACIFIC

The Asia-Pacific region commands approximately 20 % share of the global Surgical Sealants and Adhesives Market as of 2023. Rapid growth in surgical capacity, rising middle-class healthcare access, and regulatory liberalization underpin growth. In China alone, forecasts estimate the adhesive market may reach about USD 1,300 million by 2030. In India and Southeast Asia, adhesive adoption rates remain relatively low roughly 20 % of major hospitals but expansion is accelerating. In 2023, Asia-Pacific new product registrations accounted for around 18 % of global adhesive filings. Within Asia, synthetic adhesives (especially cyanoacrylates) hold 55 % share of usage, favored for their low cost and ease of storage. Biological adhesives are rising, constituting 30 % share in advanced Chinese and Japanese hospitals. Application segments: general surgery constitutes over 25 % of demand, while orthopedic and cardiovascular surgeries grow fast. In 2023, Asia-Pacific procurement growth for surgical adhesives rose by 10 % year-over-year in hospital tenders. Regulatory reforms such as priority review of medical devices in China cut review times by nearly 6 to 12 months. In nations like South Korea, Japan, and Australia, hospital penetration of adhesive use in surgeries is approaching 50 %. However, in lateral markets such as Vietnam, Indonesia, and Philippines, penetration remains under 15 %. B2B strategies often involve joint ventures with domestic players: around 30 % of foreign adhesive firms in APAC operate via partnerships or licensing. In Surgical Sealants and Adhesives Market Insights, Asia-Pacific is often identified as the fastest-growing region by value and volume, with rising capital outlays by governments to upgrade hospital infrastructure driving demand.

Asia is forecast at USD 550.00 million, about 21.6 % share in 2025, and anticipated to grow at 10.0 % CAGR to 2034.

Asia – Major Dominant Countries in the Surgical Sealants and Adhesives Market

• China: USD 200.00 million, 36.4 % share, CAGR 10.2 %
• Japan: USD 120.00 million, 21.8 % share, CAGR 9.5 %
• India: USD 80.00 million, 14.5 % share, CAGR 10.5 %
• South Korea: USD 50.00 million, 9.1 % share, CAGR 10.0 %
• Australia: USD 30.00 million, 5.5 % share, CAGR 9.8 %

MIDDLE EAST & AFRICA

The Middle East & Africa (MEA) region currently holds around 5 % to 6 % share of the global Surgical Sealants and Adhesives Market. In 2023, its adhesive market size is estimated at USD 420 million equivalent in procurement volume, with projections pointing toward USD 820 million equivalent over the next decade. Key markets include Saudi Arabia, UAE, South Africa, and Egypt. Usage in MEA is concentrated in premium hospitals and referral centers, where surgical volumes in complex procedures warrant adhesive adoption. Natural/biological adhesives hold a 50 % share of usage in MEA, while synthetic adhesives represent the balance favored due to cost and import stability. In application, general surgery dominates with 30 % share, followed by cardiovascular and neurosurgery segments. Procurement contracts in MEA often bundle adhesives with surgical kits; roughly 35 % of adhesive purchases are part of integrated surgical consumables deals. Regulatory frameworks vary: in the Gulf Cooperation Council (GCC), 2023 data indicates that 40 % of adhesive product registrations were fast-tracked via unified medical device registration systems. Some African nations still require complete local trials, elongating registrations by 18 months or more. B2B expansion strategies in MEA often emphasize local warehousing: around 20 % of major adhesive suppliers in 2023 maintained regional distribution hubs in UAE or South Africa. Growth in MEA is also benefiting from medical tourism infrastructure; countries like UAE and Saudi Arabia are expanding surgical centers, boosting local demand by 12 % year-on-year. However, price sensitivity in lower-income nations means 25 % of tender rounds exclude high-end adhesives, limiting penetration.

The Middle East & Africa region accounts for around USD 300.00 million, about 11.8 % share in 2025, with an expected CAGR of 9.0 % through 2034.

Middle East and Africa – Major Dominant Countries in the Surgical Sealants and Adhesives Market

• Saudi Arabia: USD 80.00 million, 26.7 % share, CAGR 9.3 %
• United Arab Emirates: USD 60.00 million, 20.0 % share, CAGR 9.2 %
• South Africa: USD 50.00 million, 16.7 % share, CAGR 9.1 %
• Egypt: USD 40.00 million, 13.3 % share, CAGR 9.0 %
• Nigeria: USD 20.00 million, 6.7 % share, CAGR 9.5 %

List of Top Surgical Sealants and Adhesives Market Companies

• Johnson & Johnson (Ethicon, Inc.)
• Baxter International, Inc.
• Braun Melsungen AG
• Becton, Dickinson and Company (BD)
• R. Bard, Inc.
• CryoLife, Inc.
• Cohera Medical, Inc.
• Integra LifeSciences Holdings Corporation
• Medtronic plc
• Cardinal Health, Inc.
• Vivostat A/S
• Advanced Medical Solutions Group plc
• Adhezion Biomedical, LLC
• Sealantis Ltd
• Ocular Therapeutix, Inc.
• CSL Limited
• Stryker Corporation
• 3M Company
• Henkel AG & Co. KGaA
• Chemence Ltd.
• Dentsply Sirona
• GluStitch, Inc.
• Arkema Group
• Mactac
• Nitto Denko Corporation
• Ashland
• Avery Dennison Corporation
• Poly Medicure Ltd
• Raaj Medisafe India Ltd
• Shinva Medical Instrument Co. Ltd.
• Global Medical Group Limited
• Maxmed Health Care LTD
• Highlight Surgicals
• Medcaptain Europe
• Easy Medical Devices
• Td Medical B.V.
• Ophtec B.V.
• Rovers Medical Devices B.V.
• Gem Srl
• Tricol Biomedical, Inc.
• Adhezion Biomedical
• Advanced Medical Solutions Israel / Sealantis
• Terumo
• Tissium
• Grunenthal
• Polyganics
• SkinStitch, LLC
• Hemostasis, LLC
• Péters Surgical
• Chemence Medical, Inc.
• Mullins / small specialty firms
• CryoLife’s related entities (e.g. Artivion)

Top Two Companies with Highest Market Shares

• R. Bard, Inc.: C.R. Bard, Inc. stands as one of the top leaders in the Surgical Sealants and Adhesives Market, holding an estimated 15 % global market share in 2023. As a subsidiary under the Becton, Dickinson and Company (BD) umbrella, C.R. Bard has maintained a strong position in surgical closure, hemostasis, and tissue repair solutions. The company’s extensive product portfolio includes biologically derived and synthetic sealants widely utilized in cardiovascular, thoracic, and general surgery procedures. Its focus on biocompatible hemostatic sealants and fibrin-based adhesives has made it a preferred supplier among hospitals and surgical centers across North America and Europe. With more than 20 manufacturing and R&D facilities worldwide, C.R. Bard continuously invests in material innovation, surgical delivery systems, and advanced biomaterial research. In 2023 alone, the company allocated approximately 12 % of its R&D budget toward developing next-generation polymeric adhesives with superior tissue bonding and resorption properties. The firm’s wide distribution network covers over 90 countries, serving major B2B clients such as hospitals, surgical supply chains, and healthcare procurement agencies. Its global leadership in the Surgical Sealants and Adhesives Market Report is reinforced by quality consistency, strong regulatory compliance, and a proven record of successful clinical outcomes.
• Cohera Medical, Inc.: Cohera Medical, Inc. ranks as the second top company in the Surgical Sealants and Adhesives Market, commanding approximately 8 % market share in 2023, primarily in the specialty hybrid adhesive segment. Founded in Pittsburgh, USA, Cohera Medical is renowned for its innovative, fully synthetic, biodegradable adhesive platforms. Its flagship product line, TissuGlu®, is the world’s first FDA-approved internal surgical adhesive for large-flap procedures, including abdominoplasty and reconstructive surgeries. The company’s technology focuses on lysine-based urethane prepolymers, which provide high bonding strength and natural resorption within the body, reducing the need for surgical drains and follow-up interventions. In 2023, Cohera Medical expanded its research collaboration network to over 40 hospitals and universities globally and launched three new product development initiatives centered on minimally invasive applications and advanced hybrid polymer adhesives. Cohera’s internal testing and clinical studies demonstrated a 25 % reduction in postoperative fluid accumulation when using its adhesives compared to conventional sutures. With a presence in more than 25 countries, the company continues to strengthen its position in the Surgical Sealants and Adhesives Industry Report, particularly through partnerships with device manufacturers and distributors in Europe and North America. Its innovative product design, regulatory achievements, and commitment to sustainability make Cohera Medical a prominent force in next-generation surgical adhesive technology.

Investment Analysis and Opportunities

Investment in the Surgical Sealants and Adhesives Market has accelerated: in 2023, USD 300 million in equity investments and strategic acquisitions was recorded across key adhesive firms globally. Over 40 % of that capital flowed into startup technologies (e.g. smart adhesives, adhesives with embedded sensors). Investors are especially targeting novel synthetic adhesives and combination antimicrobial-sealant platforms. For instance, in 2023, one leading manufacturer raised USD 50 million in Series C to commercialize a sensor-capable sealant slated for launch in 2025. Private equity interest is growing: three buyout deals in 2022–2023 in the surgical adhesive space totaled over USD 120 million. Opportunities include expansion of local production in emerging markets: by establishing regional manufacturing, companies can reduce import duties (typically 10 %–15 %) and logistics margins (often 8 %–12 %). In Southeast Asia, local capacity investments accounted for 25 % of new capital allocation in 2023 among top players. Another opportunity lies in licensing and co-development with hospitals; about 30 % of major adhesive firms reported that institutional partnerships were central to growth strategies. B2B investors are also eyeing adjacent markets, such as wound closure beyond surgery (e.g. emergency care), where adhesive technologies for non-operative settings could represent a 20 % expansion of addressable market. Moreover, repurposing adhesives for veterinary surgery is under trial in 2023, and could yield 10 % incremental sales over five years. Lastly, consolidation is ongoing: over 20 % of top tier adhesive firms engaged in acquisitions between 2021 and 2023 to capture emerging technologies or geographic reach.

New Product Development

Innovation in the Surgical Sealants and Adhesives Market is strongly driven by advancements in biomaterials, polymer science, and minimally invasive surgery techniques. Nearly 42% of newly developed surgical sealants introduced between 2023 and 2025 incorporate synthetic polymer formulations, which provide stronger adhesion and faster hemostasis compared with conventional sutures used in approximately 60% of surgical wound closures globally. These innovations support improved tissue sealing within 30–60 seconds, reducing operative time during procedures that can exceed 90 minutes in complex surgeries.

Another major development trend in the Surgical Sealants and Adhesives Market Analysis involves biodegradable and bioresorbable adhesives. Approximately 38% of new product launches focus on bioresorbable materials, which dissolve naturally in the body within 7–14 days, eliminating the need for removal procedures and reducing postoperative complications by nearly 20%. Natural fibrin-based adhesives are widely used in cardiovascular and hepatic surgeries, where more than 15 million procedures globally involve bleeding management and tissue sealing annually.

Technological innovation is also improving product delivery systems. Nearly 33% of surgical adhesive systems now use dual-syringe applicators, ensuring precise mixing and controlled application in delicate surgical environments such as neurosurgery and ophthalmic surgery. Additionally, antimicrobial sealant coatings have been integrated into about 25% of next-generation surgical adhesives, reducing the risk of surgical site infections that affect approximately 2–5% of hospital surgical procedures worldwide. These developments are strengthening the Surgical Sealants and Adhesives Market Outlook by expanding clinical applications across general surgery, cardiovascular procedures, and orthopedic operations.

Five Recent Developments (2023–2025)

• In 2024, C.R. Bard expanded its surgical adhesive product portfolio by introducing a synthetic tissue sealant designed for laparoscopic procedures, demonstrating sealing effectiveness in over 95% of surgical incision closures during clinical evaluations.
• In 2023, Cohera Medical enhanced its polymer-based surgical adhesive technology capable of providing tissue bonding strength up to 3 times stronger than conventional fibrin-based sealants, supporting improved wound closure stability.
• In 2025, Kuraray America developed an advanced bioresorbable adhesive used in cardiovascular surgeries, capable of sealing tissue surfaces within less than 45 seconds while maintaining elasticity during cardiac movement cycles exceeding 60 beats per minute.
• In 2024, Tissuemed introduced a surgical sealing patch technology designed for pulmonary surgery procedures, reducing air leakage complications by nearly 30% in thoracic operations involving lung tissue repairs.
• In 2023, Cohera Medical expanded clinical evaluation trials for its adhesive platform across more than 50 hospitals globally, demonstrating improved postoperative healing rates in over 80% of surgical wound closure cases.

Report Coverage of Surgical Sealants and Adhesives Market

The Surgical Sealants and Adhesives Market Report provides comprehensive insights into product innovations, surgical applications, healthcare infrastructure demand, and regional adoption patterns. The Surgical Sealants and Adhesives Market Research Report evaluates industry dynamics through analysis of Surgical Sealants and Adhesives Market Size, Surgical Sealants and Adhesives Market Share, and Surgical Sealants and Adhesives Market Trends across hospitals, clinics, and specialized surgical centers. Globally, more than 310 million surgical procedures are performed annually, creating significant demand for advanced tissue closure technologies.

Within the Surgical Sealants and Adhesives Industry Analysis, segmentation highlights that synthetic sealants represent nearly 45% of product utilization, while natural or biological sealants account for approximately 35%, reflecting the widespread use of fibrin-based adhesives in cardiovascular and general surgeries. Semisynthetic adhesives contribute around 20% of product adoption, particularly in reconstructive and orthopedic procedures.

The Surgical Sealants and Adhesives Industry Report also analyzes application-based demand. Hospitals represent approximately 70% of product usage, followed by clinics and ambulatory surgical centers contributing nearly 20% of procedural demand, while other healthcare facilities account for roughly 10% of total product utilization.

Surgical Sealants and Adhesives Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2792.48 Million in 2026
Market Size Value By	USD 6320.11 Million by 2035
Growth Rate	CAGR of 9.5% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Synthetic Surgical Sealants and Adhesives Semisynthetic Surgical Sealants and Adhesives Natural/Biological Surgical Sealants and Adhesives By Application : Hospitals Clinics Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample